Introduction
Since the 1970s, when the relationship between marine n-3 fatty acids (n-3 FAs) and cardiovascular disease (CVD) was first reported in Inuit studies, (Bang et al., 1971; Dyerberg et al., 1975) numerous studies have reported the effect of n-3 FAs on CVD and its risk factors (He et al., 2002; Balk et al., 2004 Balk et al., , 2006a Mozaffarian and Rimm, 2006; Harris et al., 2008) . These studies have found that marine n-3 FAs reduce coronary heart disease deaths and all cause mortality, and may have beneficial effects on other CVD outcomes, such as heart failure and stroke (Balk et al., 2004; Wang et al., 2006; Marchioli et al., 2009) .
Other studies have examined effects of marine n-3 FAs on individual CVD risk factors. The inverse relationship between marine n-3 FAs and triglycerides has been the strongest and most consistent finding (Balk et al., 2004) . Marine n-3 FAs are associated with a 10 to 33% decrease in triglycerides in a dose-dependent manner. Additionally, marine n-3 FAs are associated with a small but significant decrease in blood pressure as well as with an increase in heart rate variability in survivors of myocardial infarction (Balk et al., 2004) . However, the relationships between marine n-3 FAs and other CVD risk factors, including low-density lipoprotein cholesterol (LDL-C), glucose, insulin and C-reactive protein (CRP), are inconclusive (Balk et al., 2004 (Balk et al., , 2006b ). Another such risk factor is fibrinogen (Balk et al., 2004) .
Fibrinogen levels have been established as a risk factor for both coronary heart disease and stroke (Bots et al., 2002) . Fibrinogen has a major role in thrombosis, the formation of blood clots, which is a central mechanism in stroke and myocardial infarction. The Fibrinogen Studies Collaboration found that the adjusted hazard ratio per 1 g/l increase in usual fibrinogen levels for coronary heart disease and stroke was 1.8, and concluded that the associations of fibrinogen level with coronary heart disease or stroke did not differ substantially according to sex, smoking, blood pressure or blood lipid levels (Danesh et al., 2005) .
No previous study has examined the association of fibrinogen with serum levels of marine n-3 FAs among populations with wide range of fish consumption. Fish consumption in Japan is among the highest in the world, whereas fish consumption in Western countries is generally low (Zhang et al., 1999) . Based on data from the Food and Agriculture Organization, percent energy from fish is 6.5% in Japan, 0.81 % in Australia, 0.71% in the USA and 0.70% in the UK. The International Study of Macro-and MicroNutrients and Blood Pressure (Stamler et al., 2003b) , which provides the most comprehensive dietary data across Japan, China, the UK and the USA, shows that mean dietary intake of marine n-3 FAs for men aged 40-59 is 1.32 g/day in Japan, 0.03 g/day in China, 0.43 g/day in the UK and 0.21 g/day in the USA (Stamler et al., 2003a) .
In this study we examine the association of serum marine n-3 FAs with plasma fibrinogen levels, analyzing data from the 'Electron-Beam Tomography, Risk Factor Assessment among Japanese and U.S. Men in the Post-World War II Birth Cohort' (ERA-JUMP) study, a population-based crosssectional study of Japanese, white and Japanese-American men aged 40-49 (Sekikawa et al., 2008) .
Subjects and methods

Subjects and basic measurements
During 2002 to 2006, 926 men aged 40-49 were randomly selected: 310 whites from Allegheny County, Pennsylvania, USA, (Abbott et al., 2007; Sekikawa et al., 2007 Sekikawa et al., , 2008 313 Japanese from Kusatsu, Shiga, Japan, and 303 Japanese Americans whose fathers participated in the Honolulu Heart Program (Kagan et al., 1974) , Honolulu, Hawaii, USA. These offspring were third or fourth generation Japanese Americans without ethnic admixture (Abbott et al., 2007) . All participants were without clinical CVD, type 1 diabetes or other severe diseases (Sekikawa et al., 2007) . Additionally, the current study excluded subjects who were taking lipid-lowering medications. Our final sample consisted of 262 whites, 302 Japanese and 229 Japanese Americans. Informed consent was obtained from all participants. The study was approved by the Institutional Review Boards of University of Pittsburgh, Pittsburgh, USA, Shiga University of Medical Science, Otsu, Japan and Kuakini Medical Center, Honolulu, USA.
All participants underwent a physical examination, lifestyle questionnaire and laboratory assessment as described previously (Abbott et al., 2007; Sekikawa et al., 2007 Sekikawa et al., , 2008 . Body weight and height were measured while the participant was wearing light clothing without shoes. Body mass index (BMI) was calculated by dividing weight (kg) by the square of height (m 2 ). Blood pressure was measured in the right arm of the seated participant after the participant emptied his bladder and sat quietly for 5 min, using an automated sphygmomanometer (BP-8800; Colin Medical Technology, Komaki, Japan) with an appropriate-sized cuff. The average of two measurements was used.
Venipuncture was performed early in the clinic visit after a 12-h fast. Serum samples were stored at À80 1C and shipped on dry ice to the University of Pittsburgh. Serum lipids, including total cholesterol, high-density lipoprotein cholesterol (HDL-C) and triglycerides, were analyzed using the standardized methods according to the Centers for Disease Control and Prevention. LDL-C was subsequently determined using the Friedewald equation (Sekikawa et al., 2007) . LDL-C was directly measured by an automated spectrophotometric assay (Equal Diagnostics, Exton, PA, USA) when the levels of triglycerides exceeded 10.7 mmol/l. CRP was determined using a calorimetric-competitive enzyme-linked immunosorbent assay. Plasma fibrinogen was determined using an automated-clot-rate assay (Diagnostica Stago, Parsippany, NJ, USA).
Serum fatty acids were analyzed by capillary gas-liquid chromatography (Clarus 500, PerkinElmer, Inc., Waltham, MA, USA) (Sekikawa et al., 2008) . Marine n-3 FAs were defined as the sum of eicosapentaenoic acid (EPA) (20:5n-3), docosapentaenoic acid (22:5n-3) and docosahexaenoic acid (DHA) (22:6n-3). The coefficients of variation for EPA, docosapentaenoic acid and DHA were 2.5%, 2.5% and 7.0%, respectively. Fatty acids were expressed as a percent of total serum fatty acids.
Hypertension was defined as systolic blood pressure X140 mm Hg, diastolic blood pressure X90 mm Hg or use of anti-hypertensive medications. Diabetes mellitus was defined as fasting serum glucose level X7 mmol/l or use of anti-diabetic medications.
A self-administered questionnaire was used to obtain information on demography, smoking habits, alcohol drinking and other factors. Alcohol drinking was assessed as whether the participant drank beer, wine, liquor, sake (Japanese rice wine) or other alcoholic beverages, with quantity and frequency. Ethanol consumption per day was estimated, assuming that concentrations of alcohol were 5% for beer, 12% for wine, 40% for liquor and 16% for sake.
Statistical analyses
To compare risk factors among populations, analysis of variance for continuous variables except for triglycerides, CRP and ethanol or the Mantel-Haenszel test for categorical variables were used. To compare triglycerides, CRP and ethanol, which had skewed distributions among populations, the Kruskal-Wallis test was used. To examine correlation between fibrinogen and each of the continuous risk factors, Spearman's correlation test was used. To examine associations of serum marine-derived n-3 FAs with fibrinogen, we conducted multivariable-adjusted linear regression analyses for each of the three populations. In model I, we adjusted for age, BMI, current smoking, which are commonly reported as confounders of fibrinogen and are major determinants of fibrinogen (The Fibrinogen Studies Collaboration, 2007) . In model II, we further adjusted for diabetes, triglycerides, HDL-C, LDL-C and CRP, which are reported as strong confounders of fibrinogen but may not be necessarily causally related to fibrinogen (The Fibrinogen Studies Collaboration, 2007) . In model III, we further adjusted for hypertension and ethanol. Triglycerides, CRP and ethanol were log transformed in these multiple regression models. Statistical significance was considered to be Po0.05. All statistical analyses were performed with PSAW Statistics 18 (Release 18.0.0, IBM Corporation, Armonk, NY, USA). Table 1 describes the baseline characteristics of the three population samples. It should be noted that fibrinogen levels were significantly different among the three groups (Po0.05); Japanese and Japanese-American men had the lowest and highest levels, respectively. Additionally, BMI varied significantly between the three groups. Although the percentage of current smokers did not differ significantly between whites (8.0%) and Japanese Americans (13.7%), the difference between both groups and Japanese men (49.3%) was striking.
Results
Marine n-3 FAs in the Japanese was about twice as high as those in whites or Japanese Americans and overlapped little between the Japanese and the other two samples (Table 1) . The lower 25 percentile of the Japanese (5.86%) was higher than the upper 25 percentiles of whites (4.53%) and Japanese Americans (5.94%). Levels of total fatty acids were not significantly different among the three population samples (mean ± s.d. was 239 ± 52 mg/dl for whites, 244 ± 52 for the Japanese in Japan and 236 ± 81 mg/dl for Japanese Americans).
Fibrinogen had associations with various risk factors. Fibrinogen had significant positive correlations with each of the BMI and CRP in each sample population (Table 2) . Fibrinogen had positive correlations with systolic BP, LDL-C and triglycerides and had negative correlations with HDL-C in all sample populations (Table 2) . Fibrinogen was significantly higher among current smokers than non-smokers in the Japanese. Mean ± s.d. was 7.79 ± 1.94 mmol/l for current smokers (n ¼ 149) and 7.23±1.91 mmol/l for non-smokers (n ¼ 153) (P ¼ 0.010). Fibrinogen was higher in current smokers than in non-smokers in the other two population samples, but the difference did not reach statistical significance (data not shown). Similarly, fibrinogen was Po0.017 between the Japanese and Japanese-American men. Hypertension was defined as systolic blood pressure X140 mm Hg, diastolic blood pressure X90 mm Hg or use of anti-hypertensive medications. Diabetes mellitus was defined as fasting serum glucose level X7 mmol/l or use of anti-diabetic medications. Marine n-3 fatty acids were defined as the sum of eicosapentaenoic, docosapentaenoic and docosahexaenoic acids. significantly higher in those with hypertension than those without hypertension and in those with diabetes than those without diabetes in the Japanese. Mean ± s.d. was 8.00±1.76 mmol/l for those with hypertension (n ¼ 77) and 7.53±1.97 mmol/l for those without hypertension (n ¼ 225) (P ¼ 0.011). Likewise, mean ± s.d. was 8.41 ± 1.97 mmol/l for those with diabetes (n ¼ 17) and 7.47±1.94 mmol/l for those without diabetes (n ¼ 285) (P ¼ 0.048). Fibrinogen was higher in those with hypertension or diabetes than in those without hypertension or diabetes, respectively, in the other two population samples, but the difference did not reach statistical significance (data not shown).
Age-adjusted analyses show that fibrinogen was inversely associated with marine n-3 FAs in the Japanese (Table 3 ). The inverse association became significant after further adjusting for current smoking and BMI (model I). The significant inverse association remained after further adjusting for diabetes, triglycerides, HDL-C, LDL-C and CPR (model II) as well as hypertension and ethanol (model III). However, fibrinogen had no significant associations with marine n-3 FAs in either the whites or Japanese Americans.
Discussion
A significant inverse association between serum marine n-3 FAs and plasma fibrinogen was observed only in Japanese men, whose serum marine n-3 levels were about twice as high as white and Japanese-American men. This populationbased study is the first study reporting that the association of serum n-3 FAs and fibrinogen is different by the background level of marine n-3 FAs.
We observed that levels of fibrinogen differ across population groups. The observation that Japanese men in Japan had lower levels of fibrinogen than the other two groups is consistent with the results from previous studies (Iso et al., 1993; Miura et al., 2006) . We also observed that levels of fibrinogen are significantly higher in Japanese American than white men. This observation is inconsistent with the results from a few previous studies. Elderly Japanese-American men had lower levels of fibrinogen than elderly white men (Yano et al., 1999) and middle-aged Japanese-American women had lower levels of fibrinogen than middle-aged white women (Matthews et al., 2005) . This discrepancy may be due to differences in confounders of fibrinogen (The Fibrinogen Studies Collaboration, 2007) . For example, our study of men shows that BMI, a significant confounder of fibrinogen, is similar between Japanese Americans and whites whereas the study of women shows that Japanese Americans have lower BMI than whites by four units (Matthews et al., 2005) .
We observed that fibrinogen was positively associated with BMI and CRP in each population group and that fibrinogen was higher in smokers as well as those with diabetes. These observations are consistent with previous studies (The Fibrinogen Studies Collaboration, 2007) . Although some of the associations in our study did not reach statistical significance, this is likely to be due to a small sample size.
Results from epidemiological studies on the association of fibrinogen with intake of either fish or marine n-3 FAs are conflicting. The Atherosclerosis Risk in Communities (ARIC) Study reported that fibrinogen has a significant inverse association with fish intake after adjusting for age, race, BMI, smoking, diabetes, alcohol and other factors (Shahar et al., 1993) . In contrast, the Coronary Artery Risk Development in Young Adults (CARDIA) Study reported that fish intake or dietary intake of marine n-3 FAs does not have a significant association with fibrinogen (Archer et al., 1998) . The discrepancy may be partly due to the difference in intake of EPA and DHA: mean intake of EPA þ DHA in the ARIC Study is 0.27 g/day whereas that in the CARDIA Study ranges from 0.09 to 0.18 g/day depending on race and sex. These data are not inconsistent with our results. One study comparing the association of fish intake with fibrinogen between Japanese and white men and women reported that total fish intake has a significant inverse association with fibrinogen only in white men but not white women or Japanese men or women (Iso et al., 1993) . However, the study did not adjust for potential confounders, and the sample size, that is, 150 whites and 150 Japanese, is much smaller than the current study. Although results from randomized clinical trials of marine n-3 FAs on fibrinogen are conflicting, this may be partly due to the small number and short duration of these studies. A recent review of 22 trials reported that only four trials show a statistically significant difference in fibrinogen levels between n-3 FAs group and control group (Balk et al., 2004) . Three of these studies show significant decrease of fibrinogen whereas one study shows a significant increase. Another study suggested that lower doses of marine n-3 FAs are ineffective in lowering fibrinogen; Radack et al. (1989) found that dyslipidemic subjects given 2.2 g of EPA and DHA daily for 20 weeks had a statistically significant net reduction in fibrinogen, whereas subjects who took 1.1 g of EPA and DHA had no effect. However, other studies using much higher doses of EPA and DHA did not show a significant reduction in fibrinogen (Toft et al., 1997; Grundt et al., 1999; Nordoy et al., 2000) . These randomized clinical trials are small in number, for example, 15 to 40, and short in duration, for example, 2 weeks to 2 years, either of which may have attenuated existing effects. In fact, a study of the effect of marine n-3 FAs on fibrinogen of 365 subjects for 7 years showed a significant reduction in fibrinogen in a timedependent manner (Saynor and Gillott, 1992) .
The differences in the association of serum n-3 FAs with fibrinogen we observed among white, Japanese and Japanese-American men could also be related to the method of marine n-3 FAs consumption rather than amount. Cobiac et al. conducted a small study comparing equal fish oil intake through fish consumption and supplements in healthy men. After 3 weeks, the fish group showed a significant decrease in fibrinogen by 0.13 g/l as compared with the control group. In contrast, the fish oil group showed a nonsignificant increase in fibrinogen by 0.38 g/l. The authors suggest that complementary compounds in fish flesh may be required for the decrease in fibrinogen (Cobiac et al., 1991) .
We excluded subjects taking statin because statins have variable effects on fibrinogen (Rosenson and Tangney, 1998) . Some studies reported an increase and some a decrease in fibrinogen by statin, whereas other studies showed no change. When we analyzed the data including those with lipid-lowering medications, the significant inverse association of marine n-3 FAs with plasma fibrinogen remained in Japanese men. After adjusting for age, BMI, current smoking, diabetes, triglycerides, HDL-C, LDL-C, CRP and lipid-lowering medications, standardized beta for marine n-3 was À0.11 (P ¼ 0.034). After further adjusting for hypertension and ethanol standardized beta for marine n-3 was À0.10 (P ¼ 0.0499).
We have previously reported that triglycerides have a significant inverse and HDL-C has a nonsignificant inverse association with marine n-3 FAs (Motoyama et al., 2009) . We further examined the association of marine n-3 FAs with CRP, BP and BMI (data not shown). Marine n-3 FAs did not have a significant association with CPR after adjusting for age, BMI and current smoking in either group. Crosssectional studies in Japan among 14 191 subjects aged 40-69 (Ohsawa et al., 2008) but not among 3 017 subjects aged 35-60 (Yoneyama et al., 2007) show the significant association of dietary intake of EPA and DHA with CRP. Thus our result is likely due to a small sample size. Marine n-3 FAs had a significant association with systolic BP after adjusting for age, BMI and current smoking, only in whites but not in Japanese or Japanese Americans. Although clinical trials of marine n-3 FAs on BP show a small but significant reduction in BP, (Balk et al., 2004 ) a large population-based study shows an inverse but nonsignificant association of dietary marine n-3 FAs with BP after carefully adjusting for potential confounders . Thus the significant association observed in whites is likely to be due to unmeasured residual factors. Marine n-3 FAs did not have a significant association with BMI in the Japanese. The result is consistent with the results from previously reported crosssectional studies in Japan (Nakamura et al., 2005; Niu et al., 2006; Ohsawa et al., 2008) . In contrast, marine n-3 FAs did have a significant inverse association with BMI in whites and Japanese Americans. We believe the significant inverse association is not due to the effect of omega-3 fatty acids. Clinical trials of fish oil supplementation on body weight show that fish oil supplementation alone does not change body weight, but fish oil supplementation has an additive effect when combined with exercise (Mori et al., 1999; Krebs et al., 2006; Hill et al., 2007) . The results of Japanese studies described above also support the idea that marine n-3 FAs are not a major determinant of BMI. Thus we believe the significant inverse association is due to confounding factors, for example, healthy lifestyle among fish eaters in Japanese Americans and whites.
Marine n-3 FAs can reduce fibrinogen through several mechanisms. Marine n-3 FAs reduce thrombin generation, which is causally associated with fibrinogen (Vanschoonbeek et al., 2004) . In mice, marine n-3 FAs can downregulate the hepatic expression of the peroxisome proliferator-activated receptor-a (Takahashi et al., 2002) , which controls fibrinogen levels in humans (Gervois et al., 2001) .
Strengths of our study include that having data from the Japanese in Japan, whose fish consumption is one of the highest in the world, allowed us to analyze the association of a wide range of marine n-3 FAs with fibrinogen. We would also like to acknowledge several limitations. The sample size is relatively small. Serum marine n-3 FAs reflect short-term dietary intake and may not reflect long-term dietary intake. However, because the variation in serum marine n-3 FAs occurs randomly, the actual association of marine n-3 FAs with fibrinogen is likely to be stronger than that observed in the current study. Our study examined only men aged 40-49 and the results are not generalizable to women or other age groups. The study is observational and we cannot exclude the possibility of residual or unmeasured confounding, that is, other dietary factors and total energy intake (Willett et al., 1997; Miura et al., 2006) .
In conclusion, we observed the significant inverse association of marine n-3 FAs with fibrinogen in Japanese, but not in Japanese Americans or Whites. This observation suggests that marine n-3 FAs at very high levels, as seen in the Japanese, may decrease plasma fibrinogen levels.
